Special populations (Q37570949)

21 August 2017

1 reference

title

Special populations (English)

1 reference

21 August 2017

Brigitte Fauroux

1

1 reference

21 August 2017

publication date

1 June 2009

1 reference

Paediatric Respiratory Reviews

21 August 2017

published in

1 reference

21 August 2017

volume

10 Suppl 1

1 reference

21 August 2017

page(s)

21-22

1 reference

Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

The burden of respiratory syncytial virus infection in young children

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Lower respiratory tract illness and RSV prophylaxis in very premature infants

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Improved outcomes with home-based administration of palivizumab: results from the 2000-2004 Palivizumab Outcomes Registry

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

1 reference

https://api.crossref.org/works/10.1016/S1526-0542(09)70010-7

7 January 2021

10.1016/S1526-0542(09)70010-7

Identifiers

DOI

1 reference

21 August 2017

1 reference